Pyrls

Minneapolis, United States

Pyrls is a drug summaries resource for learning and managing therapy points and clinical pearls about more than 500 leading medicines.

$500K raised

Mar 2022

Pre-Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Pyrls raised?

Pyrls has raised $500K in total funding. The most recent round was Pre-Seed. The last funding was announced in March 2022.

Who are Pyrls's investors?

Pyrls's investors include Y Combinator.

Where is Pyrls headquartered?

Pyrls is headquartered in Minneapolis, United States.

What does Pyrls do?

Pyrls is a drug summaries resource for learning and managing therapy points and clinical pearls about more than 500 leading medicines.

What stage is Pyrls at?

Pyrls is at the Pre-Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 9, 2022.

MLA

"Pyrls — Funding & Investors." VCBacked, March 9, 2022, https://www.vcbacked.co/company/pyrls. Accessed July 1, 2026.

APA

VCBacked. (2022). Pyrls — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/pyrls

Wikipedia (cite web)

{{cite web |title=Pyrls — Funding & Investors |url=https://www.vcbacked.co/company/pyrls |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 9, 2022.